Autotransfusion System Market Size Share Trends and Forecast 2023-2030

Global Autotransfusion System Market Achieves Remarkable Growth, Reaching US$ 321.4 Million in 2022

Projections indicate a surge to US$ 482.6 Million by 2030, With a CAGR of 5.3%

The global Autotransfusion System Market has demonstrated substantial growth, reaching a valuation of US$ 321.4 million in 2022 and is anticipated to escalate to US$ 482.6 million by 2030. This significant expansion is projected to occur at a robust Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period from 2023 to 2030.

Autotransfusion systems play a pivotal role in the medical domain, efficiently processing blood collected from surgical sites to produce washed red blood cells for subsequent reinfusion into patients. This streamlined process is achieved through a singular kit and program, ensuring minimal deterioration of clotting factors and cells as blood is stored at room temperature for a short duration. Notable advantages of autotransfusion systems include reduced costs compared to predeposit transfusion methods and minimal wastage, as the majority or entirety of the collected blood is reinfused.

The market's growth is further propelled by the escalating number of surgeries globally, coupled with the persistent challenge of donor scarcity. The North American region is witnessing a surge in market activity, attributed to notable players such as LivaNova, Atrium Medical Corporation, Fresenius Kabi, Armstrong Medical, Beijing ZKSK Technology, Medtronic, among others. The region is experiencing an uptick in product launches and FDA approvals, consolidating its position in the global Autotransfusion System Market.

Autotransfusion System Market Scope

Metrics:

CAGR: 5.3%

Size Available for Years: 2021-2030

Forecast Period: 2023-2030

Data Availability: Value (US$)

Segments Covered:
Product Type
Techniques
Application
End User
Region

Regions Covered:
North America
Europe
Asia-Pacific
South America
Middle East & Africa

Fastest Growing Region: Asia-Pacific

Largest Region: North America

Report Insights Covered:
Competitive Landscape Analysis
Company Profile Analysis
Market Size, Share, Growth
Demand and Recent Developments
Mergers and Acquisitions
New Product Type Launches
Growth Strategies
Revenue Analysis
Porter's Analysis
Pricing Analysis
Regulatory Analysis
Supply-Chain Analysis
Other Key Insights

Download Sample: https://www.datamintelligence.com/download-sample/autotransfusion-system-market

Autotransfusion System Market Dynamics

Increase in Surgeries with Maximum Blood Loss Boosts Global Autotransfusion System Market Growth

Patients experiencing heart failure, necessitating cardiac surgeries, contribute to a significant demand for autotransfusion systems. The prevalence of heart failure, estimated at nearly 6.5 billion Americans over the age of 20, underscores the need for cardiac surgeries. These procedures often result in substantial blood loss, emphasizing the increased adoption of autotransfusion systems during the forecast period.

The utilization of intraoperative autotransfusion (IAT) during cardiac surgery has been proven to reduce allogeneic red blood cell transfusion, mitigating the risks associated with intraoperative blood loss. This, in turn, fuels the growth of the Autotransfusion System Market.

Increase in the Unavailability of Donors Drives Autotransfusion Market

A significant increase in the unavailability of donors, exacerbated by factors such as travel restrictions and pandemic-related fears, is driving the adoption of autotransfusion systems. The World Health Organization (WHO) reports a substantial decrease in voluntary donations during the pandemic, contributing to a global shortage of blood products. This shortage, causing an estimated daily loss of 12,000 lives, is a pressing public health concern. The reluctance of individuals to donate blood due to various factors further fuels the expansion of the autotransfusion system market.

High Cost Poses Challenge to Autotransfusion System Market Growth

While the benefits of autotransfusion systems are evident, their high cost poses a challenge to market growth. Each transfusion, costing hospitals approximately $500 - $1,200 per 500ml unit of blood, adds up to an annual expenditure of $1.7 - $8 billion. The cost of the system itself further hampers market growth, presenting a potential barrier to widespread adoption.

To know more Insights: https://www.datamintelligence.com/research-report/autotransfusion-system-market

Autotransfusion System Market Segment Analysis

The global autotransfusion system market is segmented based on product type, technique, application, and end user.

Product Types:
Intraoperative Autotransfusion Systems
Postoperative Autotransfusion Systems
Dual-Mode Autotransfusion Systems
Autotransfusion Accessories

Techniques:
Predeposit Autologous Donation (PAD)
Acute Normovolaemic Haemodilution (ANH)
Perioperative Cell Salvage (PCS)

Applications:
Orthopedic
Neurology
Cardiology
Others

End Users:
Hospitals
Specialty Clinics
Others

Regions:
North America
The U.S.
Canada
Mexico
Europe
Germany
The U.K.
France
Italy
Spain
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Middle East and Africa

Autotransfusion System Market Geographical Share:

North America Remains Dominant Region, Accounting for 39.9% Market Share in 2022

Key players' strategic initiatives contribute to North America's dominant position in the global Autotransfusion System Market, with a 39.9% market share in 2022. Fresenius Kabi, a leading global medical technology company, recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the next-generation software for the Cell Saver Elite+ Autotransfusion System, further boosting regional growth.

San Diego Blood Bank's launch of Innovative Precision Blood Expansion on April 24, 2023, adds to the region's momentum. This groundbreaking technology, utilizing 300 antigen markers, transforms the standard of care for patients by reducing blood transfusion reactions. These product approvals and launches significantly contribute to driving the Autotransfusion System Market in North America.

Autotransfusion System Market Companies

Major Global Players:
BD
Fresenius Kabi
Zimmer
Armstrong Medical
Beijing ZKSK Technology
Haemonetics
LivaNova
Terumo BCT
Atrium Medical Corporation
Medtronic

By Product Type:
Intraoperative Autotransfusion Systems
Postoperative Autotransfusion Systems
Dual-Mode Autotransfusion Systems
Autotransfusion Accessories

By Technique:
Predeposit Autologous Donation (PAD)
Ac

Related Reports:

Hematology Testing Products Market: https://www.datamintelligence.com/research-report/hematology-testing-products-market

Embolotherapy Market: https://www.datamintelligence.com/research-report/embolotherapy-market

Hematology Analyzers and Reagents Market: https://www.datamintelligence.com/research-report/hematology-analyzers-and-reagents-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.